Physician profile
Benjamin Tabibian
NPI 1609192426
$7,379.58
in general payments reported to CMS, 2019-2025
21 companies · $405 in 2025
The $405 reported for 2025 was more than what a typical Critical Care Medicine (Internal Medicine) provider received nationally (typical 2025 total: $189).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $415 · 2020: $216 · 2021: $55.84 · 2022: $126 · 2023: $188 · 2024: $5,974 · 2025: $405.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $5,500 · Food and Beverage: $735 · Travel and Lodging: $332.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $5,500.00 |
| Food and Beverage | $734.87 |
| Travel and Lodging | $332.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $5,837.65 | 2023-2024 | Da Vinci Surgical System |
| Inquis Medical, INC. | $249.16 | 2025 | Aventus |
| Bayer Healthcare Pharmaceuticals INC. | $140.60 | 2019-2020 | |
| Stryker Corporation | $136.19 | 2025 | Flowtriever |
| United Therapeutics Corporation | $129.25 | 2019 | |
| Siemens Medical Solutions USA, INC. | $128.94 | 2024 | |
| Allergan, INC. | $124.86 | 2020 | |
| Inari Medical, INC. | $116.40 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Olympus America INC. | $114.36 | 2022 | |
| Merck Sharp & Dohme LLC | $88.80 | 2019-2025 | Zerbaxa, Recarbrio, Dificid |
| Abiomed | $81.96 | 2021-2023 | Impella |
| Boehringer Ingelheim Pharmaceuticals, INC. | $43.88 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $34.40 | 2020-2021 | |
| Becton, Dickinson and Company | $32.82 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $24.36 | 2020 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $21.38 | 2019 | |
| Veran Medical Technologies, INC. | $19.79 | 2019-2020 | |
| Cook Medical LLC | $17.08 | 2023 | Blue Rhino |
| Glaxosmithkline, LLC. | $13.20 | 2019 | |
| Advanced Respiratory, INC | $12.72 | 2019 | |
| Electromed, INC. | $11.78 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Tabibian listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.